Oxford Index Browse

You are looking at 1-5 of 5 items for:

Psychology x Clinical Pharmacology and Therapeutics x clear all

Refine by type

Refine by product

 

antiparkinsonian

Overview page. Subjects: Clinical Pharmacology and Therapeutics — Psychology.

(Of or relating to) any drug that alleviates parkinsonism or the pseudo-parkinsonian side-effects of neuroleptic drugs such as the phenothiazines. In particular, l-dopa or bromocriptine...

See overview in Oxford Index

atomoxetine

Overview page. Subjects: Clinical Pharmacology and Therapeutics — Psychology.

The generic name of a drug for the treatment of attention-deficit/hyperactivity disorder (ADHD), developed by Eli Lilly and first marketed in January 2003. It is administered in the form...

See overview in Oxford Index

isocarboxazid

Overview page. Subjects: Psychology — Clinical Pharmacology and Therapeutics.

A monoamine oxidase inhibitor (MAOI), derived from hydrazine, used as an antidepressant drug. Also called Marplan (trademark).

See overview in Oxford Index

paraldehyde

Overview page. Subjects: Psychology — Clinical Pharmacology and Therapeutics.

A colourless strong-smelling liquid obtained from acetaldehyde and sulphuric acid that acts as a central nervous system depressant and is used as a sedative-hypnotic drug. Formula C6H12O3....

See overview in Oxford Index

tranylcypromine

Overview page. Subjects: Psychology — Clinical Pharmacology and Therapeutics.

The most stimulating, dopaminergic, and relatively fast-acting of the monoamine oxidase inhibitor (MAOI) drugs, chemically related to amphetamine and used in its sulphate form to treat...

See overview in Oxford Index